铜化学计量校准铜蓝蛋白活性实现摩尔定量并用于非铜蓝蛋白结合铜估算
研究在训练集(n=924)中建立铜蓝蛋白铁氧化酶活性与血清铜的线性关系,基于每分子铜蓝蛋白含6个铜原子的化学计量推导转换因子(0.0030),并在独立验证队列(n=12,635)中应用,建立活性法与NCC参考区间,发现与免疫比浊法相比存在正偏倚及分析干扰。
要点
- 铜蓝蛋白铁氧化酶活性经0.0030转换因子可表达为摩尔浓度。
- 活性法参考区间男性1.5-3.7 μmol/L,女性1.6-4.3 μmol/L。
- 与免疫比浊法比较存在正偏倚,部分样本有分析干扰。
核心结论
- 铜蓝蛋白铁氧化酶活性可通过化学计量转换因子换算为摩尔浓度,并用于估算NCC,但NCC估算存在相当大的不确定性。
研究设计与样本
- 训练数据集n=924用于定义铜蓝蛋白活性与血清铜的线性关系并推导转换因子;独立验证队列n=12,635用于应用该因子并建立参考区间。
主要发现
- 基于每分子铜蓝蛋白含6个铜原子的化学计量,校准所得转换因子为0.0030,用于将铜蓝蛋白活性表达为摩尔单位。
- 铜蓝蛋白活性参考区间男性为1.5-3.7 μmol/L,女性为1.6-4.3 μmol/L。
- 与免疫比浊法铜蓝蛋白测定比较显示正偏倚,并在部分样本中存在分析干扰证据。
关键数值与推荐
- 转换因子0.0030(基于每分子铜蓝蛋白含6个铜原子的化学计量)。
- 铜蓝蛋白活性参考区间:男性1.5-3.7 μmol/L,女性1.6-4.3 μmol/L。
临床怎么用
- 酶活性法测定铜蓝蛋白可作为免疫法的成本有效且分析稳健的替代方案,特异性更优。
- 基于活性法可建立参考区间并估算NCC,但需注意NCC估算的不确定性。
局限性
- NCC估算存在相当大的不确定性。
- 与免疫比浊法比较存在正偏倚,部分样本有分析干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ceruloplasmin (Cp) and non-ceruloplasmin-bound copper (NCC) are measured when evaluating liver disease and disorders of copper (Cu) metabolism. Cp mass concentration is typically determined by immunoassays that detect both apo- and holoceruloplasmin. In contrast, enzymatic assays measure Cp ferroxidase activity and are therefore specific for holoceruloplasmin. Their clinical use has been limited by the absence of a method to convert enzyme activity to molar Cp concentration and to estimate NCC. METHODS: Cp ferroxidase activity and serum Cu concentrations were measured in a training dataset (n=924) to define their linear relationship and derive a conversion factor based on the stoichiometry of six Cu atoms per Cp molecule. This factor was applied to an independent validation cohort (n=12,635). Cp activity, Cp mass concentration, and serum Cu were compared, and reference intervals for Cp activity and NCC were established. RESULTS: The calibration of Cp activity assay against Cu concentration yielded a conversion factor of 0.0030 for expressing Cp activity in molar units. Reference intervals for Cp activity were 1.5-3.7 μmol/L in males and 1.6-4.3 μmol/L in females. Comparison with nephelometric Cp measurements demonstrated a positive bias and evidence of analytical interference in a subset of samples. CONCLUSIONS: We describe a method to convert Cp ferroxidase activity to molar concentration and demonstrate its application in a large clinical cohort. This approach enables estimation of NCC, although with considerable uncertainty, and establishment of reference intervals using activity-based measurements. Measurement of Cp by enzymatic activity provides a cost-effective and analytically robust alternative to immunoassays, with advantages in specificity.
引用
- Kane AM, Giuliani KTK, Coogan M, et al. Stoichiometric calibration of ceruloplasmin activity with copper enables molar quantification and has implications for the estimation of non-ceruloplasmin-bound copper. Clin Chem Lab Med. 2026. PMID: 42723553. doi:10.1515/cclm-2026-0510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。